Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 25361192)

Published in Pediatr Infect Dis J on October 01, 2014

Authors

James A Seddon1, Anthony J Garcia-Prats, Beate Kampmann, H Simon Schaaf, Anneke C Hesseling

Author Affiliations

1: Academic Department of Paediatrics, Faculty of Medicine, Imperial College London, United Kingdom Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University Academic Department of Paediatrics, Faculty of Medicine, Imperial College London, United Kingdom Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Children's Hospital Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.

Articles citing this

Reply: To PMID 24445837. Pediatr Infect Dis J (2014) 0.75

Articles by these authors

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet (2010) 10.21

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis (2012) 4.60

A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med (2007) 4.07

Paediatric tuberculosis. Lancet Infect Dis (2008) 3.97

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine (2006) 3.16

Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA (2011) 2.90

IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol (2007) 2.75

Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med (2006) 2.68

Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2012) 2.45

Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis (2008) 2.38

Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest (2007) 2.38

A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics (2006) 2.21

Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ (2006) 2.13

Acquired drug resistance during inadequate therapy in a young child with tuberculosis. Pediatr Infect Dis J (2014) 2.02

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest (2011) 1.89

Childhood tuberculosis: an emerging and previously neglected problem. Infect Dis Clin North Am (2010) 1.78

Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis (2007) 1.72

A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci U S A (2006) 1.64

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis (2012) 1.60

Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis (2002) 1.59

A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol (2004) 1.50

Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr (2008) 1.49

Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45

Short intensified treatment in children with drug-susceptible tuberculous meningitis. Pediatr Infect Dis J (2014) 1.35

Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax (2012) 1.34

Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome. Clin Infect Dis (2011) 1.33

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One (2008) 1.32

Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child (2005) 1.30

Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med (2012) 1.30

Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child (2009) 1.29

Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr (2006) 1.29

Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol (2002) 1.29

Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol (2006) 1.28

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis (2009) 1.28

Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science (2006) 1.27

Operational challenges in managing Isoniazid Preventive Therapy in child contacts: a high-burden setting perspective. BMC Public Health (2011) 1.22

Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22

Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa--an upward trend. Am J Public Health (2009) 1.21

Paediatric use of second-line anti-tuberculosis agents: a review. Tuberculosis (Edinb) (2011) 1.19

Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy (2007) 1.17

Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J (2012) 1.11

High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study. Thorax (2013) 1.10

Clinical features and outcome in children admitted to a TB hospital in the Western Cape--the influence of HIV infection and drug resistance. S Afr Med J (2005) 1.08

Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J (2007) 1.08

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol (2013) 1.07

In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS (2014) 1.07

Symptom-based screening of child tuberculosis contacts: improved feasibility in resource-limited settings. Pediatrics (2008) 1.06

A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J (2012) 1.04

A critical look at the diagnostic value of culture-confirmation in childhood tuberculosis. J Infect (2006) 1.04

CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am J Respir Crit Care Med (2010) 1.04

Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J (2006) 1.03

Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function. J Infect Dis (2003) 1.01

A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness. BMC Med Genet (2009) 1.01

Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis (2013) 1.01

Management of children exposed to multidrug-resistant Mycobacterium tuberculosis. Lancet Infect Dis (2012) 1.00

Antimicrobial resistance in tuberculosis: an international perspective. Expert Rev Anti Infect Ther (2006) 1.00

Childhood tuberculosis: out of sight, out of mind? Trans R Soc Trop Med Hyg (2007) 1.00

Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol (2012) 1.00

Can we accurately diagnose tuberculosis infection in children? Pediatr Infect Dis J (2011) 1.00

Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction. Pediatr Infect Dis J (2013) 1.00

The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J (2006) 0.99

Paediatric emergency care in resource-limited settings. Lancet (2013) 0.99

The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J (2012) 0.99

Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J (2015) 0.98

Drug-resistant tuberculosis: pediatric guidelines. Pediatr Infect Dis J (2011) 0.98

Retooling existing tuberculosis drugs for children. Clin Infect Dis (2012) 0.98

Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis (2012) 0.98

GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot study. Pediatr Pulmonol (2013) 0.98

Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatr Infect Dis J (2012) 0.97

Early deaths during tuberculosis treatment are associated with depressed innate responses, bacterial infection, and tuberculosis progression. J Infect Dis (2011) 0.96

Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study. Clin Infect Dis (2013) 0.96

Immunology and pathogenesis of childhood TB. Paediatr Respir Rev (2010) 0.96

Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS (2014) 0.96

Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One (2013) 0.95

Soluble ecto-5'-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. J Biol Chem (2013) 0.95

Hearing loss in children treated for multidrug-resistant tuberculosis. J Infect (2012) 0.95

Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev (2008) 0.95

Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients. S Afr Med J (2012) 0.94

Enhanced anti-mycobacterial immunity in children with erythema nodosum and a positive tuberculin skin test. J Invest Dermatol (2007) 0.94

Human immunodeficiency virus infection in children hospitalised with tuberculosis. Ann Trop Paediatr (2002) 0.93

Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB gold in-tube in young children evaluated for tuberculosis in Southern India. Pediatr Infect Dis J (2014) 0.92

Achieving comprehensive childhood immunization: an analysis of obstacles and opportunities in The Gambia. Health Policy Plan (2013) 0.92

Caring for children with drug-resistant tuberculosis: practice-based recommendations. Am J Respir Crit Care Med (2012) 0.92